Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Muller

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cardiovascular Drugs and Therapy|February 2, 1999
Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme inhibitor, trandolapril, in experimental myocardial ischemia and reperfusion: antiarrhythmic and hemodynamic effects of chronic oral pretreatmentC A Muller, L H Opie, C A Pineda, et al.
The Netherlands Journal of Medicine|October 16, 2013
An uncommon cause of portal vein thrombosisI M de Jong, M C A Muller, G M Peterson, et al.
Cardiovascular Research|December 1, 1981
Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heartW F Lubbe, C A Muller, M Worthington, et al.
The American Journal of Cardiology|March 1, 1979
Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heartW F Lubbe, M L McFadyen, C A Muller, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1978
Slow-release juvenile hormone formulations for triatomine controlR Pinchin, A M Oliveira Filho, M J Figueiredo, et al.
Journal of the American College of Cardiology|July 21, 1998
Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromiseC A Muller, L H Opie, J McCarthy, et al.
Advances in Myocardiology|January 1, 1982
Cholinergic modulation of enhanced vulnerability to ventricular fibrillation evoked by adrenergic stimulation in the isolated rat heartF T Thandroyen, L M Higginson, M G Worthington, et al.
Digestive Diseases and Sciences|October 30, 2001
Hydrocortisone treatment of early SIRS in acute experimental pancreatitisB Gloor, W Uhl, O Tcholakov, et al.
The Canadian Journal of Cardiology|January 1, 1986
Regional myocardial ischemia: characterization of temporal, transmural and lateral flow interfaces in the porcine heartD J Hearse, C A Muller, M Fukanami, et al.
European Heart Journal|May 1, 1983
Calcium antagonists and the acutely ischemic heart: experimental effects on ventricular fibrillation and enzyme releaseL H Opie, F T Thandroyen, C W Hamm, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cardiovascular Drugs and Therapy|February 2, 1999
Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme inhibitor, trandolapril, in experimental myocardial ischemia and reperfusion: antiarrhythmic and hemodynamic effects of chronic oral pretreatmentC A Muller, L H Opie, C A Pineda, et al.
The Netherlands Journal of Medicine|October 16, 2013
An uncommon cause of portal vein thrombosisI M de Jong, M C A Muller, G M Peterson, et al.
Cardiovascular Research|December 1, 1981
Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heartW F Lubbe, C A Muller, M Worthington, et al.
The American Journal of Cardiology|March 1, 1979
Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heartW F Lubbe, M L McFadyen, C A Muller, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1978
Slow-release juvenile hormone formulations for triatomine controlR Pinchin, A M Oliveira Filho, M J Figueiredo, et al.
Journal of the American College of Cardiology|July 21, 1998
Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromiseC A Muller, L H Opie, J McCarthy, et al.
Advances in Myocardiology|January 1, 1982
Cholinergic modulation of enhanced vulnerability to ventricular fibrillation evoked by adrenergic stimulation in the isolated rat heartF T Thandroyen, L M Higginson, M G Worthington, et al.
Digestive Diseases and Sciences|October 30, 2001
Hydrocortisone treatment of early SIRS in acute experimental pancreatitisB Gloor, W Uhl, O Tcholakov, et al.
The Canadian Journal of Cardiology|January 1, 1986
Regional myocardial ischemia: characterization of temporal, transmural and lateral flow interfaces in the porcine heartD J Hearse, C A Muller, M Fukanami, et al.
European Heart Journal|May 1, 1983
Calcium antagonists and the acutely ischemic heart: experimental effects on ventricular fibrillation and enzyme releaseL H Opie, F T Thandroyen, C W Hamm, et al.
Pageof 5